Compound information
- Natural Products
- ZC2249510
- Molecular Formula
- C20H23ClN4O
- Molecular Weight
- 370.156039036 g/mol
- Structure
-
- IUPAC Name
- [4-(5-chloro-2-methyl-phenyl)piperazin-1-yl]-(2-cyclopropyl-6-methyl-pyrimidin-4-yl)methanone
- InChI
- InChI=1S/C20H23ClN4O/c1-13-3-6-16(21)12-18(13)24-7-9-25(10-8-24)20(26)17-11-14(2)22-19(23-17)15-4-5-15/h3,6,11-12,15H,4-5,7-10H2,1-2H3
- InChI Key
- AENUAWHWOBSATJ-UHFFFAOYSA-N
- SMILES
- Cc1cc(C(=O)N2CCN(c3cc(Cl)ccc3C)CC2)nc(C2CC2)n1
- Source
- ZINC001888881682
Warheads
- Cyclopropane
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 26 | Ring Count | 4 |
Heteroatom Count | 6 | Rotatable Bond Count | 3 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 49.33 Å2 | LogP | 3.85 |
LogS | -4.786 | LogD | 3.553 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.989 | Pgp substrate | 0.051 |
HIA | 0.974 | F20 % | 0.993 |
F30 % | 0.913 | Caco-2 | -4.619 |
MDCK | -4.866 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.064 | PPB | 92.21 |
VD | 0.967 | Fu | 1.727 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.12 | CYP1A2 substrate | 0.681 |
CYP2A6 substrate | 0.389 | CYP2B6 substrate | 0.721 |
CYP2C19 inhibitor | 0.956 | CYP2C19 substrate | 0.862 |
CYP2C8 substrate | 0.719 | CYP2C9 inhibitor | 0.799 |
CYP2C9 substrate | 0.966 | CYP2D6 inhibitor | 0.077 |
CYP2D6 substrate | 0.889 | CYP2E1 substrate | 0.139 |
CYP3A4 inhibitor | 0.705 | CYP3A4 substrate | 0.998 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.102 | CL | 3.238 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.839 | Hepatotoxicity | 0.98 |
Mutagenicity | 0.003 | Rat Oral Acute Toxicity | 0.793 |
FDAMDD | 0.769 | Skin Sensitization | 0.009 |
Carcinogenicity | 0.905 | Eye Corrosion | 0.002 |
Eye Irritation | 0.004 | Respiratory Toxicity | 0.519 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 1.486 | IGC50 | 3.308 |
LC50FM | -4.353 | LC50DM | -3.394 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.519 | NR-AR-LBD | 0.23 |
NR-AhR | 0.672 | NR-Aromatase | 0.044 |
NR-ER | 0.323 | NR-ER-LBD | 0.282 |
NR-PPAR-gamma | 0.205 | SR-ARE | 0.81 |
SR-ATAD5 | 0.543 | SR-HSE | 0.115 |
SR-MMP | 0.012 | SR-p53 | 0.154 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.